WO2008021048A3 - Procédés et compositions fondés sur l'adp-ribosyltransférase - Google Patents
Procédés et compositions fondés sur l'adp-ribosyltransférase Download PDFInfo
- Publication number
- WO2008021048A3 WO2008021048A3 PCT/US2007/017461 US2007017461W WO2008021048A3 WO 2008021048 A3 WO2008021048 A3 WO 2008021048A3 US 2007017461 W US2007017461 W US 2007017461W WO 2008021048 A3 WO2008021048 A3 WO 2008021048A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adp
- ribosyltransferase
- compositions
- based methods
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91091—Glycosyltransferases (2.4)
- G01N2333/91142—Pentosyltransferases (2.4.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne des procédés permettant d'identifier des agents qui modulent l'activité des ADP-ribosyltransférases de type sirtuine, notamment la Sirt4 et la Sirt6. L'invention concerne également des procédés permettant de traiter une maladie hyperproliférative, consistant, par exemple, à administrer à un sujet nécessitant des soins un agent qui réduit l'activité ou le niveau protéique d'une ADP-ribosyltransférase, notamment la Sirt6.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83600806P | 2006-08-07 | 2006-08-07 | |
US83603506P | 2006-08-07 | 2006-08-07 | |
US60/836,035 | 2006-08-07 | ||
US60/836,008 | 2006-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008021048A2 WO2008021048A2 (fr) | 2008-02-21 |
WO2008021048A3 true WO2008021048A3 (fr) | 2008-09-04 |
Family
ID=39082544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/017461 WO2008021048A2 (fr) | 2006-08-07 | 2007-08-06 | Procédés et compositions fondés sur l'adp-ribosyltransférase |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008021048A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008138943A2 (fr) * | 2007-05-14 | 2008-11-20 | Universite Libre De Bruxelles | Utilisation prophylactique et thérapeutique d'inhibiteurs de la sirtuine dans des pathologies à médiation par tnf-alpha |
KR102043303B1 (ko) * | 2013-03-08 | 2019-11-12 | 한국화학연구원 | Sirt7단백질의 탈아세틸화 활성을 정량분석하는 방법 및 상기 방법을 이용한 활성을 저해하는 억제제의 스크리닝 방법 |
US8962779B2 (en) | 2013-07-16 | 2015-02-24 | Dow Global Technologies Llc | Method of forming polyaryl polymers |
US9410016B2 (en) | 2013-07-16 | 2016-08-09 | Dow Global Technologies Llc | Aromatic polyacetals and articles comprising them |
US8933239B1 (en) | 2013-07-16 | 2015-01-13 | Dow Global Technologies Llc | Bis(aryl)acetal compounds |
US9063420B2 (en) | 2013-07-16 | 2015-06-23 | Rohm And Haas Electronic Materials Llc | Photoresist composition, coated substrate, and method of forming electronic device |
-
2007
- 2007-08-06 WO PCT/US2007/017461 patent/WO2008021048A2/fr active Application Filing
Non-Patent Citations (2)
Title |
---|
FRYE ET AL.: "Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity", BIOCHEM. BIPHYS. RES. COMMUN., vol. 260, no. 1, 24 June 1999 (1999-06-24), pages 273 - 279, XP002963940 * |
HONES ET AL.: "Studies of enzyme-ligand complexes using dynamic fluorescence anisotropy. II. The coenzyme-binding site of malate dehydrogenase", BIOL. CHEM. HOPPE SEYLER, vol. 367, no. 2, February 1986 (1986-02-01), pages 103 - 108 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008021048A2 (fr) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006013191D1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
WO2008076754A3 (fr) | Composés et compositions utilisés comme inhibiteurs de l'activité du récepteur cannabinoïde 1 | |
WO2006047516A3 (fr) | Composes et compositions servant d'inhibiteurs d'activite de recepteur cannabinoide de type 1 | |
NO20060871L (no) | Azepinderivater som farmasoytiske midler | |
ATE478072T1 (de) | Spiroimidazol-derivate als ppar-modulatoren | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
TNSN08373A1 (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
WO2007070052A3 (fr) | Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
MX2007009356A (es) | Compuestos y composiciones como moduladores de ppar. | |
UY28931A1 (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
TW200612926A (en) | Compounds and compositions as ppar modulators | |
WO2007127474A3 (fr) | Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase | |
WO2012027065A3 (fr) | Polythérapie pour traiter des maladies | |
WO2008115469A3 (fr) | Rôle de la signalisation par hérisson dans l'athérosclérose et les maladies cardiovasculaires | |
WO2006020680A3 (fr) | Composes heterocycliques comme agents pharmaceutiques | |
BRPI0512500A (pt) | tratamento ou condições envolvendo desmielinação | |
TW200602330A (en) | Compounds and compositions as PPAR modulators | |
NO20085338L (no) | Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav | |
WO2007056366A3 (fr) | Composes et compositions utilises en tant que modulateurs des ppar | |
WO2008021048A3 (fr) | Procédés et compositions fondés sur l'adp-ribosyltransférase | |
WO2007016338A3 (fr) | Utilisation d’inhibiteurs de la chk2 kinase pour le traitement du cancer | |
BRPI0718469A2 (pt) | Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto. | |
WO2009071689A3 (fr) | Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine | |
WO2008075173A3 (fr) | Méthodes de traitement de troubles liés au podocyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07811104 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07811104 Country of ref document: EP Kind code of ref document: A2 |